New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Heron Therapeutics, Inc.
HRTX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

281M

Biotechnology

Next Earning date - 12 Nov 2024

281M

Biotechnology

Next Earning date - 12 Nov 2024

1.85USD
Shape0.07 ( 3.93%)
favorite-chart

Relative Strenght

96
favorite-chart

Volume Buzz

-17%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

53%

Quote Panel

Shape
Updated October 26, 2024
1W 2.21 % 1M -7.04 % 3M -36.86 % 1Y 193.65 %

Key Metrics

Shape
  • Market Cap

    280.59M


  • Shares Outstanding

    151.67M


  • Share in Float

    144.07M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.85


  • Average Volume

    2.06M


  • Beta

    1.805


  • Range

    0.5-3.93


  • Industry

    Biotechnology


  • Website

    https://www.herontx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.98x

P/S Ratio

-7.15x

P/B Ratio

-4.7

Debt/Equity

-35.3%

Net Margin

$-0.3

EPS

How HRTX compares to sector?

P/E Ratio

Relative Strength

Shape

HRTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$179M

Shape398%

2025-Revenue

$0.00

Shape106%

2025-EPS

$174M

Shape-2897%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Rodman & Renshaw

initialise

Previous: Not converted

2024-06-12

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.38
vs -0.51

Q4.22

arrow
arrow

N/A

-0.17
vs -0.54

Q1.23

arrow
arrow

N/A

-0.27
vs -0.63

Q2.23

arrow
arrow

N/A

-0.35
vs -0.55

Q3.23

arrow
arrow

N/A

-0.17
vs -0.38

Q4.23

arrow
arrow

N/A

-0.07
vs -0.17

Q1.24

arrow
arrow

N/A

-0.02
vs -0.27

Q2.24

arrow
arrow

N/A

-0.06
vs -0.35

Q3.24

arrow
arrow

N/A

-0.04
vs -0.17

Q4.24

arrow
arrow

N/A

-0.02
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+14%

26.6M  vs 23.2M

Q4.22

arrow
arrow

+45%

30M  vs 20.7M

Q1.23

arrow
arrow

+26%

29.6M  vs 23.5M

Q2.23

arrow
arrow

+15%

31.8M  vs 27.6M

Q3.23

arrow
arrow

+18%

31.4M  vs 26.6M

Q4.23

arrow
arrow

+14%

34.2M  vs 30M

Q1.24

arrow
arrow

+17%

34.7M  vs 29.6M

Q2.24

arrow
arrow

+13%

36M  vs 31.8M

Q3.24

arrow
arrow

+16%

36.6M  vs 31.4M

Q4.24

arrow
arrow

+16%

39.6M  vs 34.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-187%

-1.87
vs 2.91

Q4.22

arrow
arrow

-200%

-2.00
vs -1.87

Q1.23

arrow
arrow

+284%

2.84
vs -2.00

Q2.23

arrow
arrow

+107%

1.07
vs 2.84

Q3.23

arrow
arrow

+90%

0.9
vs 1.07

Q4.23

arrow
arrow

+32%

0.32
vs 0.9

Q1.24

arrow
arrow

+9%

0.09
vs 0.32

Q2.24

arrow
arrow

+24%

0.24
vs 0.09

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

184

184
vs 171

8%

Q4.22

arrow
arrow

180

180
vs 184

-2%

Q1.23

arrow
arrow

162

162
vs 180

-10%

Q2.23

arrow
arrow

149

149
vs 162

-8%

Q3.23

arrow
arrow

140

140
vs 149

-6%

Q4.23

arrow
arrow

156

156
vs 140

11%

Q1.24

arrow
arrow

165

165
vs 156

6%

Q2.24

arrow
arrow

194

194
vs 165

18%

Earnings Growth

Latest News